Navigation Links
Reportlinker Adds Bronchitis Therapy Area Pipeline Report
Date:4/14/2011

NEW YORK, April 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Bronchitis Therapy Area Pipeline Report

http://www.reportlinker.com/p0472241/Bronchitis-Therapy-Area-Pipeline-Report.html

The Bronchitis Therapy Area Pipeline Report contains detailed information on the bronchitis drug pipeline. This report provides insight into the pipeline status of bronchitis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.

• Keep track of your competitors and partners by better understanding their product pipeline.

• Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.

• Maintain a critical competitive advantage.

Epidemiology Report

% of Products by Phase of Development

No. of Products by Phase of Development

Marketed Products vs. Pipeline Products

Company Overview - Pipeline Projects

Legend

--Top 5 Companies in Late Stage Bronchitis Products

--Top 5 Companies in Marketed Bronchitis Products

Patent Expirations

Upcoming Milestones

Product Sales

Full Pipeline View

--Product Details : Unknown/Research

--Product Details : Phase II

--Product Details : Phase III

--Product Details : Pending Approval

--Product Details : On the Market

To order this report:

Therapy Industry: Bronchitis Therapy Area Pipeline Report

Therapy Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Neuropathy Therapy Area Pipeline Report
2. Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
3. Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
4. Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
5. Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report
6. Reportlinker Adds Pancreatic Cancer Therapy Area Pipeline Report
7. Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
8. Reportlinker Adds Europe Neurology Devices Market Outlook to 2017
9. Reportlinker Adds North America Nephrology and Urology Devices Market Outlook to 2017
10. Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017
11. Reportlinker Adds Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... Advice Media, the industry leader in digital ... companies in North America and has been included in the Inc. 5000 for the second ... honored to be included in the Inc. 5000 rankings for the second year in a ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care ... accepted. , Students who successfully complete the seven-week long Patient Care Academy are ... (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , As ...
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be named to ... second year in a row. The Inc. 5000 list honors private businesses across the ... on the list once is a great accomplishment, but for us to be included ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):